|
IFT57 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.88178419700125E-15 |
| Normal-vs-Stage2 |
1.10999986979721E-10 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
8.32667268468867E-15 |
| Stage1-vs-Stage2 |
2.436300E-02 |
| Stage1-vs-Stage3 |
4.541100E-03 |
| Stage1-vs-Stage4 |
2.252200E-02 |
| Stage2-vs-Stage3 |
9.413800E-01 |
| Stage2-vs-Stage4 |
7.612200E-01 |
| Stage3-vs-Stage4 |
7.950600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.50350000000166E-05 |
| Normal-vs-Asian |
4.160500E-02 |
| Caucasian-vs-AfricanAmerican |
2.661400E-01 |
| Caucasian-vs-Asian |
8.903400E-01 |
| AfricanAmerican-vs-Asian |
7.969800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.29199995146934E-09 |
| Male-vs-Female |
1.60370000001908E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.915700E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.015650E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.501800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.391400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.110200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.925400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.367000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.527200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.262800E-01 |
| Normal-vs-Grade 2 |
1.96898053417272E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.63258295771129E-12 |
| Grade 1-vs-Grade 2 |
1.784440E-01 |
| Grade 1-vs-Grade 3 |
9.503800E-03 |
| Grade 1-vs-Grade 4 |
5.021200E-03 |
| Grade 2-vs-Grade 3 |
8.097900E-03 |
| Grade 2-vs-Grade 4 |
1.360190E-03 |
| Grade 3-vs-Grade 4 |
1.040580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.95328214608526E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
3.565100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.295660E-02 |
| N0-vs-N1 |
6.888600E-01 |
|
|
